LifeVantage Corporation

LifeVantage Corporation

LFVNยทNASDAQ

$8.32

-0.18%
Consumer DefensivePackaged Foods

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.

At a Glance

Live Snapshot
Market Cap$104.96M
EPS0.8000
P/E Ratio10.40
Earnings Date08/25/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

High confidence

Valuation multiple is compressed (P/E 10.4).

Valuation inputs: P/E 10.4, earnings yield +9.6%, momentum -0.2%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is strong (ROE +28.3%, ROIC +21.0%).

Profitability stack: net margin +4.3%, ROE +28.3%, ROIC +21.0%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Risk profile is balanced but has notable pressure points to monitor.

Risk factors: liabilities/assets +51.9%, momentum -0.2%, net margin +4.3%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

lfvn

LifeVantage Corporation Market vs Earnings Trajectory

LFVN ยท NASDAQ

Loading price and EPS data...

LifeVantage Corporation

LifeVantage Corporation Fair Value Envelope

LFVN ยท NASDAQ

Our analysis suggests that LFVN has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $8.32, this represents a potential HIDDEN relative to our calculated worth for LifeVantage Corporation.

Intrinsic Value
Current Price: $8.32
3Y+233.0%
5Y-2.0%
10Y+82.0%
3Y+11.0%
5Y-2.0%
10Y+11.0%
3Y+214.0%
5Y-15.0%
10Y+63.0%
3Y+49.0%
5Y-35.0%
10Y+98.0%
3Y+63.0%
5Y-33.0%
10Y+94.0%
3Y+2.0%
5Y+22.0%
10Y+43.0%
LifeVantage Corporation

LifeVantage Corporation Profit Bridge

LFVN ยท NASDAQ
Revenue228.53M
Cost of Goods Sold (44.86M)
Gross Profit183.67M
Operating Expenses (171.47M)
Operating Income12.20M
Interest Expense (0.00)
Other Income/Expense44.00K
Pretax Income12.24M
Income Tax (2.44M)
Net Income9.80M
Net Income
9.80M

Profitability Analysis

Gross Margin

80.4%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

5.3%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

4.3%

Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.

Effective Tax Rate

19.9%

Moderate tax rate typical for most corporations. Represents standard tax burden on profits.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

80.37%
Gross Profit Margin
1%
3Y-1.0%
5Y-4.0%
10Y-4.0%
5.34%
Operating Profit Margin
147%
3Y+45.0%
5Y+28.0%
10Y-18.0%
4.29%
Net Profit Margin
192%
3Y+184.0%
5Y-13.0%
10Y+47.0%
28.30%
Return on Equity
150%
3Y+186.0%
5Y-19.0%
10Y-43.0%
13.63%
Return on Assets
180%
3Y+209.0%
5Y-31.0%
10Y+14.0%
20.96%
Return on Invested Capital
185%
3Y+98.0%
5Y-
10Y-69.0%
LFVN

LifeVantage Corporation Cash Conversion Engine

LFVN ยท NASDAQ
Net Income9.80M
Depreciation & Amortization3.16M
Stock-Based Compensation5.70M
Change in Working Capital-6.55M
Others1.47M
Capital Expenditures-1.37M
Free Cash Flow10.51M

Cash Flow Quality Analysis

FCF Conversion Rate

107.2%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

11.5%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

+5.6%

Steady FCF growth indicates consistent cash generation improvement. On a positive trajectory.

Working Capital Impact

-$6.55M

Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโ€”monitor closely.

Cash Flow Quality Insight

Asset-light with strong cash conversion: Low capital requirements combined with efficient cash generation creates significant shareholder value through dividends, buybacks, or strategic investments.

lfvn

LifeVantage Corporation Funding & Solvency Profile

LFVN ยท NASDAQ
Cash & Cash Equivalents12.48M
Net Receivables2.42M
Inventory18.38M
Other Current Assets6.03M
Total Current Assets39 M
Property, Plant & Equipment13.76M
Goodwill & Intangible Assets3.66M
Long-Term Investments0.00
Other Non-Current Assets591.00K
Total Non-Current Assets14 M
Total Assets
62.13M

Financial Health Analysis

Current Ratio

1.96x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

0.86x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

19 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

63% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

lfvn

LifeVantage Corporation Street Expectations Map

LFVN ยท NASDAQ

Wall Street analysts project that LFVN stock may decline over the coming 12 months. The consensus 1-year price target stands at 5.00, with estimates ranging from a low of 5.00 to a high of 5.00.

Lowest Target
5.00
-39.90%
Consensus Target
5.00
-39.90%
Highest Target
5.00
-39.90%

The consensus 1-year price target stands at 5.00, with estimates ranging from a low of 5.00 to a high of 5.00.

Analyst Consensus Analysis

Upside Potential

-39.9%

Significant downside risk. Stock trading well above analyst consensus suggests elevated valuation concerns and potential correction.

Analyst Agreement

0.0% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Risk-Reward Profile

1.00x

Balanced risk-reward. Upside and downside potential relatively symmetric. Suitable for moderate risk tolerance with conviction in thesis.

Analyst Conviction

Low

Bearish or uncertain outlook. Limited upside or poor consensus suggests challenges ahead or fundamental concerns.

Market Sentiment Insight

Consensus overvaluation: Analysts agree the stock is richly valued with limited upside. Consider booking profits or defensive positioning unless you have contrarian conviction in unrecognized catalysts.

lfvn

LifeVantage Corporation Insider Positioning

LFVN ยท NASDAQ

During the last 12 months, insiders have purchased $613K and sold $745K worth of LFVN shares, resulting in $131K of net selling activity.

3 Months

Bought

1.1K

5.52K

Sold

0

0.00

Net Activity

+6K

+$6K

3-6 Months

Bought

38.0K

178.34K

Sold

0

0.00

Net Activity

+178K

+$178K

6-9 Months

Bought

54.6K

424.88K

Sold

62.2K

462.93K

Net Activity

-38K

-$38K

9-12 Months

Bought

370

4.76K

Sold

21.1K

282.05K

Net Activity

-277K

-$277K

Top Buyers

1
DJ

Dayton Judd

Director

33.2K sharesโ€ข3 transactions

$152K

2
AR

Anbalagan Rajendran

Director

13.5K sharesโ€ข1 transactions

$105K

3
BMA

Beindorff Michael A

Director

13.5K sharesโ€ข1 transactions

$105K

4
LC

Latham Cynthia

Director

13.5K sharesโ€ข1 transactions

$105K

5
GRB

Greer Raymond B

Director

13.5K sharesโ€ข1 transactions

$105K

Top Sellers

1
FSR

Fife Steven R

Director, Officer: President And Ceo

29.2K sharesโ€ข2 transactions

$360K

2
BMA

Beindorff Michael A

Director

47.8K sharesโ€ข3 transactions

$325K

3
BJ

Boyster Julie

Officer: Chief Marketing Officer

1.8K sharesโ€ข1 transactions

$18K

4
CK

Cunningham Kristen

Officer: Chief Sales Officer

1.7K sharesโ€ข1 transactions

$16K

5
AC

Aure Carl

Officer: Chief Financial Officer

1.4K sharesโ€ข1 transactions

$13K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Slightly bearish with $131K net selling. Selling modestly exceeds buying, which could be routine diversification rather than concern.

Buy/Sell Ratio

0.82:1

Moderately negative ratio. Selling is roughly double the buying, which may be routine or signal caution.

Recent Trend (3 Months)

$6K

Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.

Insider Participation

Balanced

5 insider buyers and 5 sellers. Equal participation suggests mixed or neutral insider views.

1.05%
Dividend Yield
42%
3Y+24.0%
5Y-
10Y-
ย 

lfvn Dividend History

LFVN
10Y CAGR +5%
Latest $0.05
Annual $0.185
5 year growth trend
Last Period: +11%